[1]周 政.胃息肉与幽门螺杆菌感染的关系[J].医学信息,2021,34(21):91-93.[doi:10.3969/j.issn.1006-1959.2021.21.023]
　ZHOU Zheng.Relationship Between Gastric Polyps and Helicobacter Pylori Infection[J].Medical Information,2021,34(21):91-93.[doi:10.3969/j.issn.1006-1959.2021.21.023]
点击复制

胃息肉与幽门螺杆菌感染的关系()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
34卷
期数:
2021年21期
页码:
91-93
栏目:
论著
出版日期:
2021-11-01

文章信息/Info

Title:
Relationship Between Gastric Polyps and Helicobacter Pylori Infection
文章编号:
1006-1959（2021）21-0091-03
作者:
周 政
（宣城市人民医院消化内科，安徽 宣城 242000）
Author(s):
ZHOU Zheng
(Department of Gastroenterology,Xuancheng People’s Hospital,Xuancheng 242000,Anhui,China )
关键词:
胃息肉; 幽门螺杆菌; 感染; 病理类型; 内镜粘膜下剥离术
Keywords:
Gastric polyps; Helicobacter pylori; Infection; Pathological type; Endoscopic submucosal dissection
分类号:
R573
DOI:
10.3969/j.issn.1006-1959.2021.21.023
文献标志码:
A
摘要:
目的 探讨胃息肉的临床特征及其幽门螺杆菌感染（Hp）的关系，分析不同治疗方法与胃息肉复发的关系。方法 收集2018年10月-2019年10月我院收治的胃息肉病例520例。依据幽门螺杆菌是否感染及治疗分为Hp根治组110例、非Hp根治组100例、非Hp感染组310例。分析胃息肉患者的临床特征（病理类型、部位、大小、单发及多发）与Hp感染的关系以及不同治疗方法与胃息肉复发之间的关系。结果 Hp感染率为40.38%，抗Hp成功率89.09%；增生性息肉和炎性息肉病例的Hp感染率较高；三组不同年龄、性别、息肉部位、息肉个数及大小比较，差异无统计学意义（P＞0.05）；三组不同病理类型及治疗方法比较，差异有统计学意义（P＜0.05）；采用抗Hp、内镜下粘膜切除术、内镜粘膜下剥离术治疗的胃息肉复发率分别为7.27%、24.08%、15.19%。结论 增生性息肉和炎性息肉病例的Hp感染率较高,与Hp感染有一定的关系，抗Hp、EMR和ESD方法治疗胃息肉的复发率降低。
Abstract:
Objective To explore the clinical characteristics of gastric polyps and the relationship between Helicobacter pylori infection (Hp), and analyze the relationship between different treatment methods and recurrence of gastric polyps.Methods A total of 520 cases of gastric polyps admitted to our hospital from October 2018 to October 2019 were collected. According to the infection and treatment of Helicobacter pylori, 110 cases were divided into Hp radical group, 100 cases in non-Hp radical group, and 310 cases in non-Hp infection group. The relationship between clinical features (pathological type, location, size, single and multiple) of patients with gastric polyps and Hp infection, and the relationship between different treatment methods and recurrence of gastric polyps were analyzed.Results Hp infection rate was 40.38%, and the success rate of anti-Hp was 89.09%. Hp infection rate was higher in patients with hyperplastic polyps and inflammatory polyps. There was no significant difference in age, sex, polyp location, number and size of polyps among the three groups (P>0.05); There was significant difference in different pathological types and treatment methods among the three groups (P<0.05).The recurrence rates of gastric polyps treated with anti-Hp, endoscopic mucosal resection and endoscopic submucosal dissection were 7.27%, 24.08% and 15.19%, respectively.Conclusion Hp infection rate is higher in patients with hyperplastic polyps and inflammatory polyps, which has a certain relationship with Hp infection. The recurrence rate of gastric polyps treated with anti Hp, EMR and ESD is reduced.

参考文献/References:

[1]林琳,吴静,刘揆亮,等.胃底腺息肉的临床和内镜特征分析[J].中国内镜杂志,2017,23(2):26-29.[2]Tanaka M,Kataoka H,Yagi T.Proton-pump inhibitor-induced fundic gland polyps with hematemesis[J].Clin J Gastroenterol,2019,12(2):193-195.[3]Horvath B,Pai RK.Prevalence of Helicobacter pylori in Gastric Hyperplastic Polyps[J].Int J Surg Pathol,2016,24(8):704-708.[4]魏清凤,王启琴.不同病理类型胃息肉分布及其与幽门螺杆菌感染情况的相关性分析[J].临床医学研究与实践,2020,5(30):103-104,107.[5]Robert M,Genta MD,Richard H,et al.Helicobacter pylori and gastrointestinal polyps[J].Helicobacter pylori Research,2016,10(1007):387-402.[6]Nam SY,Park BJ,Ryu KH,et al.Effect of Helicobacter pylori infection and its eradication on the fate of gastric polyps[J].Eur J Gastroenterol Hepatol,2016,28(4):449-454.[7]徐玉珍,费素娟.三种常见类型胃息肉的分布及其与幽门螺杆菌感染的关系[J].胃肠病学,2018,23(11):682-684.[8]Mitsui Y,Miyoshi A,Okamoto K,et al.Different phenotypes of gastric fundic gland polyposis and cancer in patients with familial adenomatous polyposis depending on Helicobacter pylori infection[J].Gastric Cancer,2019,22(6):1294-1300. [9]Tokunaga K,Tanaka A,Takahashi S.Gastric hyperplastic polyps and H. pylori infection, their relationship and effects of eradication therapy[J].Nihon Rinsho,2013,71(8):1449-1452.[10]朱海珍,陈志芬.2178例胃息肉的临床病理特征[J].武汉大学学报(医学版),2016,37(1):145-148.[11]Mansilla-Vivar R,Serrano CA,Palma C,et al.High Helicobacter pylori Bacterial Load and Low Cytokine Expression Levels Are Associated with Nodular Gastropathy[J].Dig Dis Sci,2020,65(2):565-575.[12]Anjiki H,Mukaisho KI,Kadomoto Y,et al.Adenocarcinoma arising in multiple hyperplastic polyps in a patient with Helicobacter pylori infection and hypergastrinemia during long-term proton pump inhibitor therapy[J].Clin J Gastroenterol,2017,10(2):128-136.[13]乔建霞.胃息肉内镜下切除术后复发危险因素分析[J].长治医学院学报,2018,32(5):369-371.[14]Back MK,Moon HS,Kwon IS,et al.Analysis of factors associated with local recurrence after endoscopic resection of gastric epithelial dysplasia: a retrospective study[J].BMC Gastroenterol,2020,20(1):148.

相似文献/References:

[1]郭绍敏.克拉霉素四联方案对一线方案根除失败的幽门螺杆菌的再根除效果评估[J].医学信息,2018,31(02):121.[doi:10.3969/j.issn.1006-1959.2018.02.044]
　GUO Shao-min.Evaluation of the Re-eradication Effect of Clarithromycin Quadruple Regimen on Helicobacter Pylori Eradication Failure in the First Line Scheme[J].Medical Information,2018,31(21):121.[doi:10.3969/j.issn.1006-1959.2018.02.044]
[2]罗宜辉,刘代华.益生菌联合四联方案根除幽门螺杆菌的临床研究[J].医学信息,2018,31(11):25.[doi:10.3969/j.issn.1006-1959.2018.11.008]
　LUO Yi-hui,LIU Dai-hua.Clinical Study on the Eradication of Helicobacter Pylori by Probiotics Combined with Quadruple Regimen[J].Medical Information,2018,31(21):25.[doi:10.3969/j.issn.1006-1959.2018.11.008]
[3]朱 玉,戴 夫,彭 琼.胃肠息肉患者血脂水平影响因素及相关性分析[J].医学信息,2019,32(02):79.[doi:10.3969/j.issn.1006-1959.2019.02.023]
　ZHU Yu,DAI Fu,PENG Qiong.Influential Factors and Correlation Analysis of Blood Lipid Levels in Patients with Gastrointestinal Polyps[J].Medical Information,2019,32(21):79.[doi:10.3969/j.issn.1006-1959.2019.02.023]
[4]魏秉秀.胃息肉患者过敏原测定结果分析[J].医学信息,2019,32(04):160.[doi:10.3969/j.issn.1006-1959.2019.04.053]
　WEI Bing-xiu.Analysis of Allergen Determination Results in Patients with Gastric Polyps[J].Medical Information,2019,32(21):160.[doi:10.3969/j.issn.1006-1959.2019.04.053]
[5]潮子健,汪文生,谢宏伟.年龄对胃部常见良性疾病患者的胃蛋白酶原及胃泌素-17水平的影响[J].医学信息,2018,31(23):105.[doi:10.3969/j.issn.1006-1959.2018.23.028]
　CHAO Zi-jian,WANG Wen-sheng,XIE Hong-wei.Effect of Age on Pepsinogen and Gastrin-17 Levels in Patients with Common Benign Diseases of the Stomach[J].Medical Information,2018,31(21):105.[doi:10.3969/j.issn.1006-1959.2018.23.028]
[6]马艳会,寇 毅.幽门螺杆菌感染与结直肠腺瘤临床特征的相关性研究[J].医学信息,2022,35(16):102.[doi:10.3969/j.issn.1006-1959.2022.16.024]
　MA Yan-hui,KOU Yi.Correlation Between Helicobacter Pylori Infection and Clinical Features of Colorectal Adenoma[J].Medical Information,2022,35(21):102.[doi:10.3969/j.issn.1006-1959.2022.16.024]
[7]华启洋,吴同利,刘永艳,等.幽门螺杆菌在胃食管反流病发病中的作用[J].医学信息,2019,32(20):103.[doi:10.3969/j.issn.1006-1959.2019.20.029]
　HUA Qi-yang,WU Tong-li,LIU Yong-yan,et al.The Role of Helicobacter Pylori in the Pathogenesis of Gastroesophageal Reflux Disease[J].Medical Information,2019,32(21):103.[doi:10.3969/j.issn.1006-1959.2019.20.029]
[8]陶源,徐俊林,张艳,等.上消化道黏膜病变病理诊断结果分析[J].医学信息,2020,33(02):125.[doi:10.3969/j.issn.1006-1959.2020.02.036]
　TAO Yuan,XU Jun-lin,ZHANG Yan,et al.Analysis of Pathological Diagnosis for Upper Gastrointestinal Mucosal Lesions[J].Medical Information,2020,33(21):125.[doi:10.3969/j.issn.1006-1959.2020.02.036]
[9]黄 飞.不同用药方案治疗幽门螺杆菌感染胃溃疡的效果比较[J].医学信息,2020,33(16):156.[doi:10.3969/j.issn.1006-1959.2020.16.050]
　HUANG Fei.Comparison of the Effects of Different Medication Regimens in the Treatment of Gastric Ulcer Infected by Helicobacter Pylori[J].Medical Information,2020,33(21):156.[doi:10.3969/j.issn.1006-1959.2020.16.050]
[10]王蓓蓓,白 梅.黄芪建中汤加减联合四联疗法对Hp阳性胃溃疡患者Hp清除率及复发率的影响[J].医学信息,2022,35(20):145.[doi:10.3969/j.issn.1006-1959.2022.20.040]
　WANG Bei-bei,BAI Mei.Effect of Huangqi Jianzhong Decoction Combined with Quadruple Therapy on Hp Clearance Rate and Recurrence Rate in Patients with Hp Positive Gastric Ulcer[J].Medical Information,2022,35(21):145.[doi:10.3969/j.issn.1006-1959.2022.20.040]

更新日期/Last Update: 1900-01-01